Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4585-4592

  Coleman, Allen E ^a   Schröck, Evelin ^b   Weaver, Zoë ^b   Du Manoir, Stan ^b   Yang, Fangteng ^c   Ferguson Smith, Malcolm A ^c   Ried, Thomas ^b   Janz, Siegfried ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CHROMOSOME ABERRATION; CYTOGENETICS; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; KARYOTYPING; MOUSE; NONHUMAN; ONCOGENE C MYC; PLASMACYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE;

ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; GENES, MYC; GENETIC MARKERS; KARYOTYPING; METAPHASE; MICE; MICE, INBRED BALB C; PLASMACYTOMA; TRANSLOCATION, GENETIC;

EID: 1842415978     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Potter, M., and Wiener, F. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis (Lond.), 13: 1681-1697, 1992.
2. Wiener, F., Babonits, M., Bregula, U., Klein, G., Leonard, A., Wax, J. S., and Potter, M. High resolution banding analysis of the involvement of strain BALB/c-and AKR-derived chromosomes no. 15 in plasmacytoma-specific translocations. J. Exp. Med., 159: 276-291, 1984.
3. Axelson, H., Panda, C. K., Silva, S., Sugiyama, H., Wiener, F., Klein, G., and Sumegi, J. A new variant 15;16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin λ. Oncogene. 6: 2263-2270, 1991.
4. Wiener, F., Silva, S., Sugiyama, H., Babonits, M., and Klein, G. The missing mouse plasmacytoma (MPC) associated translocation T(15;16) occurs repeatedly in new MPC induction systems. Genes Chromosomes & Cancer, 2: 36-43, 1990.
5. Sugiyama, H., Silva, S., Babonits, M., Potter, M., Klein, G., and Wiener, F. A murine plasmacytoma with a variant (15;16)(D2/3;B1) translocation that involves the c-myc and λ light chain gene-carrying chromosomes. Cancer Genet. Cytogenet., 46: 93-97, 1990.
6. Ohno, S., Migita, S., Wiener, F., Babonits, M., Klein, G., Mushinski, J. F., and Potter, M. Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and abelson virus. J. Exp. Med., 159: 1762-1777, 1984.
7. Janz, S., Müller, J., Shaughnessy, J., and Potter, M. Detection of recombinations between c-myc and immunoglobulin switch a in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 90: 7361-7365, 1993.
8. Müller, J. R., Potter, M., and Janz, S. Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells. Proc. Natl. Acad. Sci. USA, 91: 12066-12070, 1994.
9. Müller, J. R., Jones, G. M., Potter, M., and Janz, S. Detection of immunoglobulin/ c-myc recombinations in mice that are resistant to plasmacytoma induction. Cancer Res., 56: 419-423, 1996.
10. Müller, J. R., Jones, G. M., Janz, S., and Potter, M. Migration of cells with immunoglobulin/c-myc recombinations in lymphoid tissues of mice. Blood, 89: 291-296, 1997.
11. Wiener, F., Coleman, A., Mock, B. A., and Potter, M. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus. Cancer Res., 55: 1181-1188, 1995.
12. Liyanage, M., Coleman, A., du Manoir, S., Veldman, T., McCormack, S., Dickson, R. B., Barlow, C., Wynshaw-Boris, A., Janz, S., Wienberg, J., Ferguson-Smith, M. A., Schrock, E., and Ried, T. Multicolour spectral karyotyping of mouse chromosomes. Nat. Genet., 14: 312-315, 1996.
13. Schröck, E., du Manoir, S., Veldman, T., Schoell, B., Wienberg, J., Ferguson-Smith, M. A., Ning, Y., Ledbetter, D. H., Bar-Am, I., Soenksen, D., Garini, Y., and Ried, T. Multicolor spectral karyotyping of human chromosomes. Science (Washington DC), 273: 494-497, 1996.
14. Nordan, R. P., and Potter, M. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science (Washington DC), 233: 566-569, 1986.
15. Telenius, H., Pelmear, A. H., Tunnacliffe, A., Carter, N. P., Behmel, A., Ferguson-Smith, M. A., Nordenskjold, M., Pfragner, R., and Ponder, B. A. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes. Genes Chromosomes & Cancer, 4: 257-263, 1992.
16. Garini, Y., Macville, M., du Manoir, S., Buckwald, R. A., Lavi, M., Katzir, N., Wine, D., Bar-Am, I., Schrock, E., Cabib, D., and Ried, T. Spectral karyotyping. Bioimaging, 5: 1-8, 1997.
17. Wiener, F. Chromosomal aberrations in murine plasmacytomas. Curr. Top. Microbiol. Immunol., 113: 178-182, 1984.
18. VanNess, B. G., Shapiro, M., Kelley, D. E., Perry, R. P., Weigert, M., D'Eustachio, P., and Ruddle, F. Aberrant rearrangement of the κ light-chain locus involving the heavy-chain locus and chromosome 15 in a mouse plasmacytoma. Nature (Lond.), 301: 425-427, 1983.
19. Fahrlander, P. D., Sumegi, J., Yang, J. Q., Wiener, F., Marcu, K. B., and Klein, G. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma. Proc. Natl. Acad. Sci. USA, 32: 3746-3750, 1985.
20. Wiener, F., Ohno, S, Babonits, M., Sumegi, J., Wirschubsky, Z., Klein, G., Mushinski, J. F., and Potter, M. Hemizygous interstitial deletion of chromosome 15 (band D) in three translocation-negative murine plasmacytomas. Proc. Natl. Acad. Sci. USA, 81: 1159-1163, 1984.
21. Shaughnessy, J., Wiener, F., Huppi, K., Mushinski, J. F., and Potter, M. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes Sα to Pvt-1 in a mouse plasmacytoma. Oncogene, 9: 247-253, 1994.
22. Ohno, S., Migita, S., and Murakami, S. c-myc gene in a murine plasmocytoma without visible chromosomal translocations moves to chromosome 12F1 with Pvt-1 and rearranges with IgH enhancer-Sμ sequences. Int. J. Cancer, 49: 102-108, 1991.
23. Berberich, S., and Cole, M. The mdm-2 oncogene is translocated and overexpressed in a murine plasmacytoma cell line expressing wild-type p53. Oncogene., 9: 1469-1472, 1994.
24. Joh, T., Kagami, Y., Yamamoto, K., Segawa, T., Takizawa, J., Takahashi, T., Ueda, R., and Seto, M. Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation. Oncogene, 13: 1945-1953, 1996.
25. Taki, T., Hayashi, Y., Taniwaki, M., Seto, M., Ueda, R., Hanada, R., Suzukawa, K., Yokota, J., and Morishita, K. Fusion of the MLL gene with two different genes, AF-6 and AF-5α, by a complex translocation involving chromosomes 5, 6, 8 and 11 in infant leukemia. Oncogene, 13: 2121-2130, 1996.
26. Potter, M., Mushinski, E. B., Wax, J. S., Hartley, J., and Mock, B. A. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice. Cancer Res., 54: 969-975, 1994.
27. Gerondakis, S., Cory, S., and Adams, J. M. Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell, 36: 973-982, 1984.
28. Cory, S., Gerondakis, S., and Adams, J. M. Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. EMBO J., 2: 697-703, 1983.
29. Piccoli, S. P., Caimi, P. G., and Cole, M. D. A conserved sequence at c-myc oncogene chromosomal translocation breakpoints in plasmacytomas. Nature (Lond.), 310: 327-330, 1984.
30. Corcoran, L. M., Cory, S., and Adams, J. M. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma. Cell, 40: 71-79, 1985.
31. Eckhardt, L. A., Tilley, S. A., Lang, R. B., Marcu, K. B., and Birshtein, B. K. DNA rearrangements in MPC-11 immunoglobulin heavy chain class-switch variants. Proc. Natl. Acad. Sci. USA, 79: 3006-3010, 1982.
32. Greenberg, R., Lang, R. B., Diamond, M. S., and Marcu, K. B. A switch region inversion contributes to the aberrant rearrangement of a μ immunoglobulin heavy chain gene in MPC-11 cells. Nucleic Acids Res., 10: 7751-7761, 1982.
33. Yang, J. Q., Bauer, S. R., Mushinski, J. F., and Marcu, K. B. Chromosome translocations clustered 5′ of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation. EMBO J., 4: 1441-1447, 1985.
34. Bauer, S. R., Piechaczyk, M., Nordan, R. P., Owens, J. D., Nepveu, A., Marcu, K. B., and Mushinski, J. F. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas. Oncogene, 4: 615-623, 1989.
35. Mohit, B., and Fan, K. Hybrid cell line from a cloned immunoglobulin-producing mouse myeloma and a nonproducing mouse lymphoma. Science (Washington DC), 171: 75-77, 1971.
36. Mohit, B. Immunoglobulin G and free κ-chain synthesis in different clones of a hybrid cell line. Proc. Natl. Acad. Sci. USA, 68: 3045-3048, 1971.
37. Kennett, R. H., and Gilbert, F. Hybrid myelomas producing antibodies against a human neuroblastoma antigen present on fetal brain. Science (Washington DC), 203: 1120-1121, 1979.
38. Moav, B., Horowitz, M., Cohen, J. B., Rechavi, G., Eliyahu, E., Oren, M., and Givol, D. Structure and activity of the translocated c-myc in mouse plasmacytoma XRPC-24. Gene, 48: 297-300, 1986.
39. Potter, M. Neoplastic development in B-lymphocytes. Carcinogenesis (Lond.), 11: 1-13, 1990.
40. Potter, M., and Boyce, C. Induction of plasma cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature (Lond.), 193: 1086, 1962.
41. Gawrisch, K., and Janz, S. The uptake of pristane (2,6,10,14-tetramethylpentadecane) into phospholipid bilayers as assessed by NMR, DSC, and tritium labeling methods. Biochim. Biophys. Acta, 1070: 409-418, 1991.
42. Janz, S., and Shacter, E. A new method for delivering alkanes to mammalian cells: preparation and preliminary characterization of an inclusion complex between β-cyclodextrin and pristane (2,6,10,14-tetramethylpentadecane). Toxicology, 69: 301-315, 1991.
43. Janz, S., Gawrisch, K., and Lester, D. S. Translocation and activation of protein kinase C by the plasma cell tumor-promoting alkane pristane. Cancer Res., 55: 518-524, 1995.
44. Janz, S., Shacter, E., and Herrmann, A. Fusion between enveloped viruses and erythrocyte membranes is induced by the isoprenoid alkane pristane (2,6,10,14-tetramethylpentadecane). Cancer Biochem. Biophys., 14: 1-14, 1994.
45. Janz, S., and Shacter, E. Disposition of the plasmacytomagenic alkane pristane (2,6,10,14-tetramethylpentadecane) in mice. Cancer Biochem. Biophys., 15: 25-34, 1995.
46. Potter, M., and Robertson, C. L. Development of plasma-cell neoplasms in BALB/c mice after intraperitoneal injection of paraffin-oil adjuvant, heat-killed staphylococcus mixtures. J. Natl. Cancer Inst., 25: 847-861, 1960.
47. Merwin, R. M., and Redmon, L. W. Induction of plasma cell tumors and sarcomas in mice by diffusion chambers placed in the peritoneal cavity. J. Natl. Cancer Inst., 31: 990-1007, 1963.
48. Müller, J. R., Janz, S., and Potter, M. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations. Cancer Res., 55: 5012-5018, 1995.
49. Wax, J., and Potter, M. Plasmacytomas. Methods of induction with a catalogue of tumors and mouse strains. Catalog on NCI Contract N01-CB-21075. Bethesda, MD: NIH (NCI), 1994.
50. Potter, M. The developmental history of the neoplastic plasma cell in mice: a brief review of recent developments. Semin. Hematol., 10: 19-32, 1973.
51. Hilbert, D. M., Kopf, M., Mock, B. A., Kohler, G., and Rudikoff, S. Interleukin 6 is essential for in vivo development of B lineage neoplasms. J. Exp. Med., 182: 243-248, 1995.
52. Gattoni-Celli, S., Hsiao, W. L., and Weinstein, I. B. Rearranged c-mos locus in a MOPC 21 murine myeloma cell line and its persistence in hybridomas. Nature (Lond.), 306: 795-796, 1983.
53. Horowitz, M., Luria, S., Rechavi, G., and Givol, D. Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene. EMBO J., 3: 2937-2941, 1984.